Erythromycin

CAS 114-07-8 9 current records 14 historicalSmall Molecule

Who holds supplier records for Erythromycin? 9 organisations hold a current record for Erythromycin: an active US FDA Type II Drug Master File or a CEP. A further 14 organisations have only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4), China (2), Poland (1), United States (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Erythromycin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/erythromycin

Reading the evidence

  • 9 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 7 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (9)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Erythromycin. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Erythromycin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (7)

Certificates of Suitability on the EDQM register for Erythromycin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 17 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ERCROS S.A. AranjuezES
CEP 2025-628 - Rev 00
Erythromycin, EBII, micronised, powder
May 2026Inspected Mar 2024
Spain
ANUH PHARMA LTD. MumbaiIN
CEP 2005-205 - Rev 13
Erythromycin
Nov 2025—
Ningxia Qiyuan Pharmaceutical Co., Ltd. Yinchuan CityCN
CEP 2020-304 - Rev 02
Erythromycin
Jan 2024Inspected Sept 2024
Germany
AbbVie Inc. North ChicagoUS
R1-CEP 1997-001 - Rev 08
Erythromycin
May 2023—
CALYX CHEMICALS AND PHARMACEUTICALS LIMITED MumbaiIN
R1-CEP 2012-284 - Rev 00
Erythromycin
Apr 2020—
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
R1-CEP 2009-284 - Rev 00
Erythromycin
Jul 2017—
HEC PHARM CO., LTD. Yidu CityCN
R1-CEP 2007-153 - Rev 02
Erythromycin
Jan 2017—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (14)

Organisations whose Type II DMFs for Erythromycin are no longer active. These show a past filing, not current supply.

Show all 14 historical records
  • DIASPA TRADE MARK STRIDES ITALIA SRL
    Inactive DMF 13314 · filed Sept 1998
  • FERMIC SA DE CV
    Inactive DMF 13457 · filed Sept 1998
  • COMPANHIA INDUSTRIAL PRODUTORA DE ANTIBIOTICOS SARL
    Inactive DMF 13406 · filed Sept 1998
  • United States · Inactive DMF 13531 · filed Sept 1998
  • GEORGE UHE CO
    Inactive DMF 13436 · filed Sept 1998
  • NANTONG PHARMACEUTICAL FACTORY
    Inactive DMF 13635 · filed Sept 1998
  • United States · Inactive DMF 13336 · filed Sept 1998
  • ABBOTT LABORATORIES CHEMICAL AND AGRICULTURAL PRODUCTS DIV
    Inactive DMF 13509 · filed Sept 1998
  • DSM CAPUA SPA
    Inactive DMF 13446 · filed Sept 1998
  • ANGUS BIOTECH INC
    Inactive DMF 13721, 7567 · filed Sept 1998
  • CIBRAN
    Inactive DMF 13665 · filed Sept 1998
  • SANDOZ INDUSTRIAL PRODUCTS SPA
    Inactive DMF 13477 · filed Sept 1998
  • United States · Inactive DMF 13515 · filed Sept 1998
  • ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
    Inactive DMF 2904 · filed Apr 1977

Overview

Erythromycin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL532).

Chemical identity

IUPAC name
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
Canonical SMILES
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O
InChIKey
ULGZDMOVFRHVEP-RWJQBGPGSA-N
Synonyms
Akne-mycin, Aknemycin plus, A/t/s, C-solve-2, E-base, E-glades, Emgel, E-mycin, Eritromicina, Eryacne 2, Eryacne 4, Eryc

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Macrolide; Macrolide Antimicrobial
Physiologic effect
Decreased Sebaceous Gland Activity
Chemical structure
Macrolides

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Erythromycin?

9 organisations hold an active US FDA Type II Drug Master File or a CEP for Erythromycin: Alembic Pharmaceuticals Limited (India), Calyx Chemicals & Pharmaceuticals Ltd. (India), HEC PHARM CO (China), Ningxia Qiyuan Pharmaceutical Co., Ltd. (China), Polfa Tarchomin S.A. (Poland), UNIMAX CHEMICALS PVT LTD (India), Abbvie Inc. (United States) and Anuh Pharma Limited (India), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Erythromycin Drug Master Files are active?

Alembic Pharmaceuticals Limited (DMF 22695), Calyx Chemicals & Pharmaceuticals Ltd. (DMF 20137), HEC PHARM CO (DMF 19444), Ningxia Qiyuan Pharmaceutical Co., Ltd. (DMF 22390), Polfa Tarchomin S.A. (DMF 13409) and UNIMAX CHEMICALS PVT LTD (DMF 27031). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Erythromycin records mean?

14 organisations have only inactive Type II DMFs for Erythromycin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Erythromycin have a European Certificate of Suitability?

Yes. 7 organisations hold a valid CEP for Erythromycin on the EDQM register, including ERCROS S.A. Aranjuez (ES), ANUH PHARMA LTD. Mumbai (IN), Ningxia Qiyuan Pharmaceutical Co., Ltd. Yinchuan City (CN), AbbVie Inc. North Chicago (US), CALYX CHEMICALS AND PHARMACEUTICALS LIMITED Mumbai (IN) and ALEMBIC PHARMACEUTICALS LIMITED Vadodara (IN) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Erythromycin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Erythromycin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.